Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2006; Volume 186, Supplement 650
Joint Meeting of The German Society of Physiology and The Federation of European Physiological Societies 2006
3/26/2006-3/29/2006
Ludwig-Maximilians-University, Munich


NANOMOLAR AMBIENT ATP DECELERATES P2X3 KINETICS
Abstract number: OM05-26

Jabs1 R, Grote1 A, Steinhauser1 C

1Exp. Neurobiology, Neurosurgery, Univ. of Bonn

Recent studies demonstrated modulatory effects of low [ATP] on P2X3 receptors including receptor current enhancement (J.Nsci. 05, 25:7734) and a use-dependent receptor inhibition (J.NSci. 05, 25:7359). However, so far there is no information available about the influence of low [agonist] on the receptor gating kinetics. To address this issue, we studied the effect of ambient nanomolar [ATP] on P2X3 receptor activation and desensitization. First, we asked whether persistent ATP affects the receptor current decay. Therefor, P2X3 mediated currents, elicited by pressure application of saturating [ATP], were analyzed after 4 minutes pre-application of low [ATP]. Second, we employed UV-flash photolysis of caged ATP to investigate whether low [ATP] affects the current activation. We found that persistent low [ATP] caused a pronounced deceleration of current activation and decay. This priming effect of nanomolar [ATP] on the kinetics of P2X3 receptor gating indicates a mechanism different from use-dependent receptor inhibition. We suggest an extended dynamic model, including an additional desensitization state. Our data are in line with the hypothesis that P2X3 receptors bear a high affinity binding site already in the resting state. They are masked by fast receptor desensitization, as described already for P2X1 receptors (J.Biol.Chem. 04, 279:6426).

The slow down of P2X3 gating can be considered as an additional mechanism for fine tuning of the nociceptive system, driven by the actual endogenous agonist concentration. (Supported by DFG)

To cite this abstract, please use the following information:
Acta Physiologica 2006; Volume 186, Supplement 650 :OM05-26

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE